1 Increases in renal blood flow were produced by intra-arterial injections of dopamine (5-50 ,g) in anaesthetized dogs pretreated with a-and ,B-adrenoceptor antagonists.
Introduction
It is now established that certain vascular beds, including that supplying the kidney, possess vasodilator receptors which are specific for dopamine (see Goldberg, 1972) . Although dopamine increases blood flow in both the inner and the outer cortical zones there is an overall shift in renal blood flow from the outer two-thirds to the inner one-third of the cortex (Hardaker & Wechsler, 1973) suggesting that these dopamine receptors may be present in greater numbers in the vasculature of the inner cortex. The best documented antagonist of dopamine at these receptors is the butyrophenone, haloperidol (Rossum, 1966; Yeh, McNay & Goldberg, 1969; Schuelke, Mark, Schmid & Eckstein, 1971) , but this drug has the disadvantage of being an effective antagonist for only about 2 min after intra-arterial administration (Yeh et al., 1969; Schuelke et al., 1971) , which makes its use difficult in some situations. We are currently concerned with analysis of the intrarenal actions of dopamine (Bell & Lang, 1973) and it is therefore desirable to find other antagonists which are less evanescent in effect. This paper reports a comparative study of ergometrine, which has been shown to be an effective antagonist of dopamine in Helix ganglia (Walker, Woodruff, Glaizner, Sedden & Kerkut, 1968) , and apomorphine, which has been briefly reported as producing antagonism of dopamine in both dog kidney (Goldberg & Musgrave, 1971) and rat vas deferens (Simon & Van Maanen, 1971 ).
Methods
Mongrel dogs of either sex weighing 10-17 kg were anaesthetized with ca-chloralose (70 mg/kg i.v.) following induction with thiopentone sodium. The main left renal artery was exposed and blood flow was recorded with a cuff-type electro-magnetic flow probe. In some experiments flow in the left femoral artery was also recorded. Systemic 
Results
Average resting blood flow in the main renal artery of 13 dogs was 10.96 ± 1.19 ml min-' kg body wt-1 (mean ± s.e. mean). These flows were well maintained over the 4-6 h period of the experiment.
The agonists were injected intra-aortically and the doses used were: acetylcholine 0.1-1 ,ug, dopamine 5-50 pg and histamine 2-50 gg. Over the dose ranges selected all agonists produced increases in blood flow in the renal vascular bed. Acetylcholine and histamine produced systemic vasodepressor effects at all dose levels. The larger doses of dopamine (20-50 ig) also produced a fall in arterial blood pressure, while smaller doses had no effect. Responses to acetylcholine were abolished by intravenous administration of atropine methonitrate (0.4 mg/kg) and those to histamine were abolished or greatly reduced by intra-aortic administration of mepyramine maleate (2 mg/kg), indicating that they were Ergometrine also produced a slight increase in diastolic and a greater increase in systolic blood pressure. These effects persisted throughout the experiment after the antagonism to dopamine had worn off.
Effect ofapomorphine on renal responses
Intra-aortic injection of apomorphine 1 mg caused a transient increase in blood flow in the renal vascular bed, with no effect on blood pressure. When renal blood flow had returned to the control resting level, the recorded dilator responses to dopamine at all dose levels were depressed. However the depression was statistically significant only with the highest dose of dopamine used. When dose-response curves were constructed from the pooled data using the least squares regression method, t-test application indicated that a significant (P < 0.01) shift of the dose-response curve to the right was produced by apomorphine. Responses to acetylcholine and histamine were not depressed by apomorphine (Table 1 ). The degree of antagonism of dopamine produced by apomorphine was less than that produced by ergometrine (Table 1 ) and its effect was not maintained for more than about 10 minutes. Unlike the situation with ergometrine, further doses of apomorphine given at this time did not consistently produce further periods of dopamine antagonism. Administration of doses of 2 mg apomorphine caused vomiting and non-specific depression of all dilator stimuli. Table 1 Increments in renal arterial blood flow (ml min-' kg body wt-') produced by intra-aortic injections of dopamine, acetylcholine and histamine before and after intra-aortic administration of ergometrine (0.5 mg) or apomorphine (1 mg). (5) The number of experiments at each dose level are shown in parentheses. Values are means with se. mean. * P < 0.05; ** P < 0.01; *** P < 0.005; t Dose-response curve shifted significantly (P < 0.01) to the right.
After ergometr (0.5 mg).
0.00 ± 0.00 (3 0.07 ± 0.07 (7 0.32 ± 0.13 (8 0.76 ± 0.16 (7 The observation that both apomorphine and L-DOPA produce compulsive gnawing in rats led Ernst (1967) to suggest that apomorphine acts as an agonists at central dopamine receptors, while Goldberg, Sonneville & McNay (1968) proposed that the renal vasodilator affect of apomorphine in the dog might also be attributable to direct activation of dopamine receptors. However both Goldberg & Musgrave (1971) using the renal vasculature, and Simon & Van Maanen (1971) using the rat vas deferens noted antagonism by apomorphine of the effects of dopamine itself. It seems likely that the present observations on the relative ineffectiveness of apomorphine in antagonizing dopamine in the renal vasculature might be related to its admixture of agonist with antagonist properties.
Ergometrine was originally shown to be a specific antagonist of dopamine at the neuronal dopamine receptors in the ganglia of Helix aspersa (Walker et al., 1968) . The present results provide evidence for its also behaving as a specific dopamine antagonist in the canine renal vasculature. In addition we have recently demonstrated the presence in the canine femoral vasculature of dopamine receptors: ergometrine acts as a specific antagonist of dopamine in this situation as well (Bell, Conway & Lang, unpublished observations) . Thus at least in their susceptibility to ergometrine, the dopamine receptors in the mammalian vasculature seem to be similar to those in the Helix nervous system. Whether those present in the mammalian central nervous system are also similar remains to be seen.
